GLP-1 Pipeline Update: November 2025 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid
The components in these injections, such as methionine, inositol, and choline, are believed to promote the transport and metabolism of fats, potentially leading to improved fat burning and weight loss
Metformin, on the other hand, has a much smaller effect on weight
Eur J Med Res 28, 425 (2023)
Injectable hype is a different (riskier) conversation